Management of community-acquired pneumonia: The role of clarithromycin

Disease Management and Health Outcomes

Volumn 6, Issue 4, 1999, Pages 225-239

  Balfour, Julia A Barman ^a   Lamb, Harriet M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ANAPHYLAXIS; ANTIMICROBIAL THERAPY; CHLAMYDOPHILA PNEUMONIAE; DIAGNOSTIC TEST; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ECONOMIC EVALUATION; GLOSSITIS; HEADACHE; HUMAN; LEGIONELLA; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PNEUMONIA; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SIDE EFFECT; STEVENS JOHNSON SYNDROME; STOMATITIS; STREPTOCOCCUS PNEUMONIAE; TASTE DISORDER; THRUSH; URTICARIA; VERTIGO; VOMITING;

EID: 0032696318     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-199906040-00005     Document Type: Article

References (3)

1. Langtry HD, Brogden RN. Clarithromycin: a review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs 1997 Jun; 53: 973-1004
2. Peters DH, Friedel HA, McTavish D. Azithromycin: a review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992 Nov; 44: 750-99
3. Dunn CJ, Barradell LB. Azithromycin: a review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Drugs 1996 Mar; 51: 483-505